IBDEI0XD ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14859,1,3,0)
 ;;=3^Abnormal imaging Liver
 ;;^UTILITY(U,$J,358.3,14859,1,4,0)
 ;;=4^R93.2
 ;;^UTILITY(U,$J,358.3,14859,2)
 ;;=^5019715
 ;;^UTILITY(U,$J,358.3,14860,0)
 ;;=R94.5^^85^836^2
 ;;^UTILITY(U,$J,358.3,14860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14860,1,3,0)
 ;;=3^Abnormal liver function studies
 ;;^UTILITY(U,$J,358.3,14860,1,4,0)
 ;;=4^R94.5
 ;;^UTILITY(U,$J,358.3,14860,2)
 ;;=^5019742
 ;;^UTILITY(U,$J,358.3,14861,0)
 ;;=K70.41^^85^836^8
 ;;^UTILITY(U,$J,358.3,14861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14861,1,3,0)
 ;;=3^Alcoholic hepatic failure w/ Coma
 ;;^UTILITY(U,$J,358.3,14861,1,4,0)
 ;;=4^K70.41
 ;;^UTILITY(U,$J,358.3,14861,2)
 ;;=^5008791
 ;;^UTILITY(U,$J,358.3,14862,0)
 ;;=K70.40^^85^836^9
 ;;^UTILITY(U,$J,358.3,14862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14862,1,3,0)
 ;;=3^Alcoholic hepatic failure w/o Coma
 ;;^UTILITY(U,$J,358.3,14862,1,4,0)
 ;;=4^K70.40
 ;;^UTILITY(U,$J,358.3,14862,2)
 ;;=^5008790
 ;;^UTILITY(U,$J,358.3,14863,0)
 ;;=D13.4^^85^836^17
 ;;^UTILITY(U,$J,358.3,14863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14863,1,3,0)
 ;;=3^Benign neoplasm of Liver
 ;;^UTILITY(U,$J,358.3,14863,1,4,0)
 ;;=4^D13.4
 ;;^UTILITY(U,$J,358.3,14863,2)
 ;;=^5001976
 ;;^UTILITY(U,$J,358.3,14864,0)
 ;;=Z90.81^^85^836^4
 ;;^UTILITY(U,$J,358.3,14864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14864,1,3,0)
 ;;=3^Acquired absence of Spleen
 ;;^UTILITY(U,$J,358.3,14864,1,4,0)
 ;;=4^Z90.81
 ;;^UTILITY(U,$J,358.3,14864,2)
 ;;=^5063597
 ;;^UTILITY(U,$J,358.3,14865,0)
 ;;=F10.188^^85^836^5
 ;;^UTILITY(U,$J,358.3,14865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14865,1,3,0)
 ;;=3^Alcohol abuse w/ Other Complication
 ;;^UTILITY(U,$J,358.3,14865,1,4,0)
 ;;=4^F10.188
 ;;^UTILITY(U,$J,358.3,14865,2)
 ;;=^5003079
 ;;^UTILITY(U,$J,358.3,14866,0)
 ;;=E88.01^^85^836^13
 ;;^UTILITY(U,$J,358.3,14866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14866,1,3,0)
 ;;=3^Alpha-1-Antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,14866,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,14866,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,14867,0)
 ;;=R18.8^^85^836^14
 ;;^UTILITY(U,$J,358.3,14867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14867,1,3,0)
 ;;=3^Ascites
 ;;^UTILITY(U,$J,358.3,14867,1,4,0)
 ;;=4^R18.8
 ;;^UTILITY(U,$J,358.3,14867,2)
 ;;=^5019253
 ;;^UTILITY(U,$J,358.3,14868,0)
 ;;=R18.0^^85^836^15
 ;;^UTILITY(U,$J,358.3,14868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14868,1,3,0)
 ;;=3^Ascites,Malignant
 ;;^UTILITY(U,$J,358.3,14868,1,4,0)
 ;;=4^R18.0
 ;;^UTILITY(U,$J,358.3,14868,2)
 ;;=^5019252
 ;;^UTILITY(U,$J,358.3,14869,0)
 ;;=I82.0^^85^836^18
 ;;^UTILITY(U,$J,358.3,14869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14869,1,3,0)
 ;;=3^Budd-Chiari syndrome
 ;;^UTILITY(U,$J,358.3,14869,1,4,0)
 ;;=4^I82.0
 ;;^UTILITY(U,$J,358.3,14869,2)
 ;;=^5007846
 ;;^UTILITY(U,$J,358.3,14870,0)
 ;;=K76.1^^85^836^21
 ;;^UTILITY(U,$J,358.3,14870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14870,1,3,0)
 ;;=3^Congestive hepatopathy (Chronic Passive)
 ;;^UTILITY(U,$J,358.3,14870,1,4,0)
 ;;=4^K76.1
 ;;^UTILITY(U,$J,358.3,14870,2)
 ;;=^270307
 ;;^UTILITY(U,$J,358.3,14871,0)
 ;;=Q44.6^^85^836^22
 ;;^UTILITY(U,$J,358.3,14871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14871,1,3,0)
 ;;=3^Cystic disease of Liver
 ;;^UTILITY(U,$J,358.3,14871,1,4,0)
 ;;=4^Q44.6
 ;;^UTILITY(U,$J,358.3,14871,2)
 ;;=^5018697
